anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
PURPOSE: Though research indicates that certain aspects of adverse neighborhood conditions may influence weight development in childhood and adolescence, it is unknown if the Child Opportunity Index (COI), a composite measure of 29 indicators of neighborhood conditions, is associated with weight outcomes in adolescence. We hypothesized that lower COI would be associated with higher overweight and obesity in cross-sectional and longitudinal modeling in a national sample of 9 year olds and 10 year olds and that this association would be different by sex.
METHODS: Using data from the Adolescent Brain Cognitive Development study (n = 11,857), we examined the cross-sectional association between COI quintile and overweight and obesity in 9 year olds and 10 year olds. Additionally, we used hazard ratios to examine incident overweight and obesity across three waves of data collection.
RESULTS: Due to the interaction between sex and COI (p < .05), we present sex-specific models. There was a stepwise bivariate association, in which higher COI was associated with lower obesity prevalence. This pattern held in multilevel models, with a stronger association in females. In models adjusted for individual and household characteristics, female adolescents in the lowest quintile COI neighborhoods had 1.81 (95% confidence interval: 1.32, 2.48) times the odds of obesity compared to those in the highest quintile. In longitudinal models, the COI was associated with incident obesity in females only: adjusted hazard ratio = 4.27 (95% confidence interval: 1.50, 12.13) for lowest compared to highest COI.
DISCUSSION: Neighborhood opportunity is associated with risk of obesity in pre-adolescence into mid-adolescence. Females may be particularly influenced by neighborhood conditions.
Determining acute ischemic stroke (AIS) etiology is crucial for guidance of secondary prevention. Here, the inventors performed a correlation analysis between AIS etiology and AIS thrombus cellular composition and content, as assessed using quantitative biochemical assays. In particular, homogenates of 250 AIS patient thrombi were prepared by mechanical grinding. Platelet, red blood cell, and leukocyte content of AIS thrombi were estimated by quantification of glycoprotein (GP)VI, heme, and DNA in thrombus homogenates. AIS etiology was defined as cardioembolic, non-cardioembolic, or embolic stroke of undetermined source (ESUS), according to the TOAST classification. Cardioembolic thrombi were richer in DNA (35.8 vs 13.8 ng/mg, p<0.001) and poorer in GPVI (0.104 vs 0.117 ng/mg, p=0.045) than non- cardioembolic ones. The area under the receiver operating characteristic curve of DNA content to discriminate cardioembolic thrombi from non-cardioembolic was 0.72 (95% Cl, 0.63 to 0.81). With a threshold of 44.7 ng DNA/mg thrombus, 47% of thrombi from undetermined etiology would be classified as cardioembolic with a specificity of 90%. In conclusion, thrombus DNA content may provide an accurate biomarker for identification of cardioembolic thrombi in AIS patients with ESUS.
Chronic pain has been proven to be an independent disease, other than an accompanying symptom of certain diseases. Interleukin-18 (IL-18), a pro-inflammatory cytokine with pleiotropic biological effects, participates in immune modulation, inflammatory response, tumor growth, as well as the process of chronic pain. Compelling evidence suggests that IL-18 is upregulated in the occurrence of chronic pain. Antagonism or inhibition of IL-18 expression can alleviate the occurrence and development of chronic pain. And IL-18 is located in microglia, while IL-18R is mostly located in astrocytes in the spinal cord. This indicates that the interaction between microglia and astrocytes mediated by the IL-18/IL-18R axis is involved in the occurrence of chronic pain. In this review, we described the role and mechanism of IL-18 in different types of chronic pain. This review provides strong evidence that IL-18 is a potential therapeutic target in pain management.
PURPOSE: To investigate cases of vitreous opacity (VO) similar to asteroid hyalosis (AH) after intravitreal brolucizumab injection.
METHODS: A retrospective chart review was conducted to identify cases showing VO similar to AH among patients who received intravitreal brolucizumab injections at our retinal clinic from January 2022 to January 2023.
RESULTS: A total of 220 brolucizumab injections were administered at our hospital. VO, showing yellow-white brilliant reflective particles, was found in six patients (2.7%). When VO occurred, all patients complained of floaters, although none of them complained of other symptoms including decreased visual acuity, pain, or conjunctival redness. The mean number of brolucizumab injections was 2.57 ± 2.38. No significant visual impairment was observed while VO was present. VO improved in all cases, and four cases improved without any treatment. The mean interval from onset to disappearance of VO was 8.0 ± 3.1 weeks.
CONCLUSIONS: VO, similar to AH, can occur with a relatively high probability after intravitreal brolucizumab injections. Patients complained of severe floaters, but VO was not accompanied by other symptoms including vision impairment, injection, and pain. The VO disappeared after approximately 4 to 14 weeks. In case that other inflammatory findings are not severe, close follow-up without treatment may be sufficient. If a patient complains of floaters after an intravitreal brolucizumab injection, close fundus observation is necessary to evaluate the VO.
Participants will be treated with paroxetine (Paroxetine 10 mg daily for 1 week followed by 20 mg daily for 5 weeks) or placebo for 6 weeks. Pretreatment is followed the first study day. A single dose of LSD (0.1 mg) will be administered. Primary study endpoint are the subjective effects on consciousness (5D-ASC total score). Secondary study endpoints include additional psychological measurements, plasma concentrations of LSD and paroxetine, as well as some safety measures (autonomic effects, ECG). The washout between the first study day and the second pretreatment will be at least 2 days. In the second pretreatment period, participants will be treated with placebo or paroxetine (cross-over) for another 6 weeks. This is followed by the second study day and administration of LSD (0.1 mg).

Based on a power analysis the sample size is 24 participants (12 female and 12 male).
OBJECTIVE: To explore the relative sensitivity of different methods for detecting cervical glandular lesions.
METHODS: A total of 225 patients with cervical glandular lesions diagnosed from January 2018 to February 2023 were retrieved from the pathology database of Guangdong Maternal and Child Health Hospital, and their clinicopathological features were reviewed.
RESULTS: Four human papillomavirus (HPV) genotypes: HPV18, 16, 45, and 52, dominated all glandular lesions, and accounting for 74.10% of HPV-positive tumors. Furthermore, 36.89% of abnormal squamous cells were diagnosed as abnormal based on cytological examinations leading to the detection of cervical glandular lesions; only 16.89% were diagnosed based on the initial detection of abnormal glandular cytology. The most common abnormal cervical screening result was ASC-US on cytology (14.22%), followed by HSIL (11.56%). Only few number of patients were diagnosed with or suspected of having cervical adenopathy via a Pap test (18.22%). Nearly one-third of cervical glandular lesions cases were not detected on the Pap test; but were diagnosed upon cervical biopsy or based on the histological examination of ECC, LEEP, or CKC specimens. The LEEP or CKC biopsy specimens had negative margins in 49 cases (40.83%), while the margins were positive in the other 71 cases (59.17%). Five cases (10.20%) with negative margins still had residual lesions following total hysterectomy, and 19 (26.76%) with positive margins had no residual lesions after total hysterectomy.
CONCLUSION: The ability to detect cervical glandular lesions varies for routine HPV genotyping, Pap test, or biopsy/ECC, with different sensitivities and advantages and disadvantages for each method.
Intensive care is a multidisciplinary, professional field where patients with acute, life-threatening conditions or at risk of organ dysfunction are comprehensively managed. The primary goal of intensive care is to treat existing physical problems while maintaining the patient's physiological course and preventing deterioration. Perceiving breathing as strenuous and abnormal is defined as dyspnea. Assessing the severity of dyspnea is an important indicator for the progression of the disease. Dyspnea affects an individual's daily life, negatively impacting their ability to perform physical activities . Music therapy, as part of medical care, can be effectively used in the treatment of lung diseases and symptoms. It is enjoyable, cost-effective, and applicable almost anywhere . Music is reported to be effective as a pharmacological and non-invasive intervention in alleviating breathlessness .

The psychological and physical effects of music on humans have long been recognized. Music, by following a specific physiological pathway, can have various effects on the body, from reducing anxiety to lowering blood pressure and inducing relaxation. It is believed that negative thoughts and experiences can lead to physiological and psychological illness. Music is believed to have a profound impact on these illnesses .

There are limited studies in our country that investigate the effects of music therapy on patients admitted to intensive care with dyspnea complaints. In conclusion, dyspnea is a common problem among patients admitted to intensive care with a diagnosis of COPD. This study is planned to evaluate how music therapy affects dyspnea severity and life indicators in COPD patients admitted to intensive care. It is believed that the findings will contribute to the literature in terms of nursing care.
PURPOSE:The titled cosmetic, prepared by dissolving a fatty acid ester of ascorbic acid transparently in an esterification product of a polyether polyol obtained by adding an alkylene oxide to a polyol with a higher fatty acid, and having improved stability. CONSTITUTION:An oily beautifying and whitening cosmetic obtained by dissolving (A) a fatty acid ester of ascorbic acid, e.g. monostearate, transparently in (B) an esterification product of a polyether polyol obtained by adding an alkylene oxide to a polyol, e.g. polyethylene glycol, with a >=8C higher fatty acid, e.g. isooctylic acid. The resultant cosmetic is capable of acting rapidly on and permeating through the skin in use without causing clouding, gelation nor deterioration in the beautifying and whitening effects even on storage for a long term, and giving improved beautifying and whitening effects and good touch to the skin. The amount of the component (A) to be incorporated is 0.1-5wt%. If a liquid oily base material, e.g. olive oil, is incorporated in the cosmetic, the amount of the component (A) is 0.1-3wt%.
It has been evidenced that ROR2 influences the growth of many tumors, including non-small cell lung cancer, osteosarcoma, and breast cancer. This research examined the effect of the WNT1/ROR2 signaling pathway on the progression of triple-negative breast cancer (TNBC). Bioinformatics analysis results demonstrated that ROR2 had a higher messenger RNA (mRNA) expression level in TNBC tissues and was positively correlated with poor patient prognosis. Western blot analysis (WB) and quantitative reverse transcription polymerase chain reaction demonstrated that TNBC cells had relatively higher ROR2 mRNA and protein levels than normal cell lines. Transwell and Cell Counting Kit-8 (CCK-8) assay further proved that downregulating ROR2 expression dramatically slowed the MDA-MB-231 cell progression. WB detection of epithelial-mesenchymal transition (EMT)-related proteins suggested that knocking down ROR2 could alleviate the EMT tendency of cancer cells. The WNT1/ROR2 signaling pathway could be inhibited by the WNT inhibitor pyrvinium pamoate (PP). Experiments on in vitro cell functional recovery have demonstrated that PP could restore malignant phenotypes caused by ROR2 overexpression. Finally, the mouse model experiments further validated the anticancer effect of PP on TNBC. Generally speaking, the malignant progression of TNBC could be stimulated by the WNT1/ROR2 signaling pathway which can be inhibited by PP, suggesting the potential value of PP in controlling TNBC.
The invention belongs to the field of postprandial blood glucose response prediction, and particularly relates to a method for predicting postprandial blood glucose response of a type 1 diabetes patient. The invention firstly collects the data of type 1 diabetics, including blood sugar data, clinical characteristics, dietary nutrition content and other data. And secondly, carrying out data preprocessing, calculating the PPGR of each meal by combining the meal time and CGM data and calculating the increment area under the blood glucose curve within 2 hours after meal, and constructing a GAIN model to process the missing value. Then, a LightGBM prediction model based on an improved Bayesian optimization algorithm and a random search algorithm is constructed, and model performance is evaluated. Finally, the interpretability of the model is implemented using the SHAP method. The invention predicts the PPGR of the T1D patient by using the characteristics of clinical data, food nutrition content, blood sugar data and the like of the type 1 diabetes patient, provides a personalized method for predicting postprandial blood sugar response of the type 1 diabetes patient in China, and is convenient for the subsequent implementation of postprandial blood sugar control.
Borderline elevations of one or more liver tests may occur in up to 15% of patients taking NSAIDs including Dolobid. These laboratory abnormalities may progress, may remain unchanged, or may be transient with continuing therapy. Notable elevations of ALT or AST (approximately three or more times the upper limit of normal) have been reported in approximately 1% of patients in clinical trials with NSAIDs. In addition, rare cases of severe hepatic reactions, including jaundice and fatal fulminant hepatitis, liver necrosis and hepatic failure, some of them with fatal outcomes have been reported.

A patient with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormal liver test has occurred, should be evaluated for evidence of the development of a more severe hepatic reaction while on therapy with Dolobid . If clinical signs and symptoms consistent with liver disease develop, or if systemic manifestations occur (e.g., eosinophilia, rash, etc.), Dolobid should be discontinued.
The launcher has a spring-loaded breech block, to which and to the sliders is coupled a control. An igniter contains a spring-loaded striker pin. A shell bearing is enclosed in a housing, at least partly. The breech block (202) and the slider control has a cam lever (302) mounted on the housing (102) and extending along the movement path. The lever comprises a control cam (304), or an engaging follower. The breech block has a complementary follower (222), or a control cam so that the lever carries out transverse swivel during the breech block motion. The cam lever is coupled to the sliders by a linkage converting the lever swivel into the slider alternating motions.
<P>PROBLEM TO BE SOLVED: To provide a treating agent of mental disorders, a method for screening the treating agent, a method for diagnosing such disorders, etc.  <P>SOLUTION: This preventing/treating agent of the mental disorders contains a substance accelerating the expression or function of CaMKIIα as an active ingredient. The method for screening the substance capable of treating/preventing the mental disorders is provided by including the evaluation of a test substance determining whether it can accelerates the expression or function of the CaMKIIα or not, and the selection of the substance capable of accelerating the expression or function of the CaMKIIα as the substance capable of preventing/treating the mental disorders. The method for determining the onset or onset risk of the mental disorders is provided by including the measurement of the expressed amount or function of the CaMKIIα in a living body specimen. The method for determining the onset risk of the mental disorder is provided by including the detection of polymorphism in the CaMKIIα gene.  <P>COPYRIGHT: (C)2007,JPO&INPIT
A depilatory comprises an aqueous solution of thioglycolic acid and, as thickening agent, an alkylmercaptoethanesulphonic acid or a water-soluble salt thereof.  Preferably the alkyl-mercaptoethane sulphonic acid has an alkyl group containing 8 to 20 carbon atoms e.g. dodecylmercaptoethanesulphonic acid and the salt may be the sodium, potassium or ammonium salt.  Optional agents are reducing agents and keratin protective agents such as cystine and methionine.ALSO:A liquid permanent waving preparation comprises an aqueous solution of thioglycolic acid and, as thickening agent, an alkylmercaptoethanesulphonic acid or a water-soluble salt thereof. Preferably the alkylmercaptoethane sulphonic acid has an alkyl group containing 8 to 20 carbon atoms e.g. dodecylmercaptoethanesulphonic acid and the salt may be the sodium, potassium or ammonium salt. Optional agents are reducing agents and keratin protective agents such as cystine and methionine.
Objective: To evaluate auditory spatial discrimination capabilities in patients with mild to moderately severe symmetrical sensorineural hearing loss (SNHL) and to compare the impact of different psychophysical testing methods on Minimum Audible Angle (MAA) and test duration. Methods: A total of 105 symmetrical SNHL patients aged from 18 to 60 years old were enrolled from April to July 2023, including 56 males and 49 females. They were divided into three groups based on PTA: mild, moderate, and moderately severe hearing loss, with 35 individuals in each group. Additionally, a control group of 35 individuals with normal hearing was tested, including 18 males and 17 females. Participants underwent four distinct psychophysical discrimination tests: the block up-down, 1-up/1-down, 1-up/2-down, and 1-up/3-down procedures. We recorded the MAA and test duration for each. We employed repeated measures of ANOVA to compare the MAA and test duration across different methods and groups, and Pearson's correlation to assess the relationship between MAA and degree of hearing loss. Results: MAA of sound localization in patients with symmetrical SNHL was significantly positively correlated with the degree of hearing loss (r=0.59, P<0.01). Significant deterioration in MAA was observed as hearing loss progressed to the moderate level (PTA≥35 dBHL, P<0.01). The testing methods significantly influenced MAA and testing duration (F=24.02, P<0.01; F=75.56, P<0.01) and the 1-up/1-down method was the quickest, averaging only (0.69±0.32) mins. Conclusions: The horizontal plane auditory spatial discrimination abilities in patients with symmetrical SNHL is impaired progressively with increasing hearing loss, notably beyond moderate hearing loss levels. Different psychophysical methods influence both MAA and test duration, the quicker 1-up/1-down method is recommended for assessing MAA in symmetrical SNHL patients.
PROBLEM TO BE SOLVED: To provide technology to construct a large framework to offer beauty/health care related service by using the present infrastructure, which thus far has not been available. SOLUTION: This system is constituted, by including second information processors Y to be managed by a person to offer the beauty/health care related service, a first information processor X to manage connection with them and terminals T to be used by a user. They can communicate with each other via the Internet, etc. The user connects the terminal T with the first information processor X and transmits identification information. If the identification information is recognized to be correct by the first information processor X, the terminal T can be connected with one of the second information processors Y. The user transmits information to indicate the second information processor Y the communication with which is desired to the first information processor X.  The first information processor X permits communication between the terminal T and the second information processor Y the communication with which is desired by the terminal T. The terminal T transmits basic information, such as image information to the second information processor Y and receives processing data generated, based on the basic information, from the second information processor.
Patients undergo External Beam Radiation Therapy (EBRT). Beginning 1 week prior to start of EBRT, patients receive metformin hydrochloride PO QD for 3 days and BID thereafter until 2 weeks after completion of EBRT.
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder currently affecting the ageing population. Although the aetiology of PD has yet to be fully elucidated, environmental factors such as exposure to the naturally occurring neurotoxin rotenone has been associated with an increased risk of developing PD. Rotenone inhibits mitochondrial respiratory chain (MRC) complex I activity as well as induces dopaminergic neuronal death. The aim of the present study was to investigate the underlying mechanisms of rotenone-induced mitochondrial dysfunction and oxidative stress in an in vitro SH-SY5Y neuronal cell model of PD and to assess the ability of pre-treatment with Coenzyme Q10 (CoQ10) to ameliorate oxidative stress in this model. Spectrophotometric determination of the mitochondrial enzyme activities and fluorescence probe studies of reactive oxygen species (ROS) production was assessed. Significant inhibition of MRC complex I and II-III activities was observed, together with a significant loss of neuronal viability, CoQ10 status, and ATP synthesis. Additionally, significant increases were observed in intracellular and mitochondrial ROS production. Remarkably, CoQ10 supplementation was found to reduce ROS formation. These results have indicated mitochondrial dysfunction and increased oxidative stress in a rotenone-induced neuronal cell model of PD that was ameliorated by CoQ10 supplementation.
Local infiltration of knee joint using 40ml of bupivacaine 0.25% with adrenaline 1:200 000, diluted to 150ml with saline 0.9%. This is then divided into thirds; 50ml into the posterior capsule before cementing, 50ml into the medial and lateral capsules and 50ml into subcutaneous tissues and in and around the vastus medialis and sartorius muscles (where it may block the saphenous nerve).
Atypical porcine pestivirus (APPV) is a novel member of the Pestivirus genus detected in association with congenital tremor (CT) type A-II outbreaks and from apparently healthy pigs, both as singular infection and as part of multi-pathogen infections. 'Classical' pestiviruses are known to cause immunosuppression of their host, which can increase susceptibility to secondary infections, severely impacting health, welfare, and production. To investigate APPV's effect on the host's immune system and characterise disease outcomes, 12 piglets from a natural APPV CT type A-II outbreak were experimentally infected with porcine reproductive and respiratory syndrome virus (PRRSV), a significant porcine pathogen. Rectal temperatures indicating febrile responses, viremia and viral-specific humoral and cellular responses were assessed throughout the study. Pathological assessment of the lungs and APPV-PRRSV co-localisation within the lungs was performed at necropsy. Viral co-localisation and pathological assessment of the lungs (Immunohistochemistry, BaseScope in situ hybridisation) were performed post-mortem. APPV status did not impact virological or immunological differences in PRRSV-infected groups. However, significantly higher rectal temperatures were observed in the APPV+ve/PRRSV+ve group over four days, indicating APPV increased the febrile response. Significant differences in the lung consolidation of the apical and intermediate lobes were also present, suggesting that APPV co-infection may augment lung pathology.